Home  »  Analyst Insights   »  Teva Pharmaceutical Industries Limited (TEVA) 14-d...

Teva Pharmaceutical Industries Limited (TEVA) 14-day ATR is 0.27: This Stock is Set to Soar Above its Peers

Teva Pharmaceutical Industries Limited (NYSE: TEVA) established initial surge of 0.37% at $8.20, as the Stock market unbolted on December 14, 2021. During the day, the stock rose to $8.395 and sunk to $8.01 before settling in for the price of $8.17 at the close. Taking a more long-term approach, TEVA posted a 52-week range of $7.94-$13.30.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


>> 7 Top Picks for the Post-Pandemic Economy << 

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -3.30%. Meanwhile, its Annual Earning per share during the time was -32.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -297.90%. This publicly-traded company’s shares outstanding now amounts to $1.10 billion, simultaneously with a float of $1.09 billion. The organization now has a market capitalization sitting at $9.22 billion. At the time of writing, stock’s 50-day Moving Average stood at $9.18, while the 200-day Moving Average is $9.90.

While finding the extent of efficiency of the company that is accounted for 39717 employees. It has generated 1,442,475 per worker during the last fiscal year. Meanwhile, its income per employee was -345,488. The stock had 3.34 Receivables turnover and 0.32 Total Asset turnover. For the Profitability, stocks gross margin was +46.38, operating margin was +18.36 and Pretax Margin of -26.45.

Teva Pharmaceutical Industries Limited (TEVA) Ownership Facts and Figures

Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Teva Pharmaceutical Industries Limited industry. Teva Pharmaceutical Industries Limited’s current insider ownership accounts for 1.05%, in contrast to 48.00% institutional ownership. According to the most recent insider trade that took place on Aug 10, this organization’s Executive VP, Global R&D sold 50,860 shares at the rate of 9.95, making the entire transaction reach 506,021 in total value, affecting insider ownership by 41,412. Preceding that transaction, on May 21, Company’s Executive VP Global Operations sold 40,000 for 11.01, making the whole transaction’s value amount to 440,320. This particular insider is now the holder of 33,128 in total.

Teva Pharmaceutical Industries Limited (TEVA) Earnings and Revenue Records

Going through the last 3-months fiscal report unveiled on the 6/29/2021, it has been observed that the corporation posted $0.59 earnings per share (EPS) during the time that was better the consensus figure (set at $0.59) by $0. This company achieved a net margin of -23.95 while generating a return on equity of -34.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.73 per share during the current fiscal year.

Teva Pharmaceutical Industries Limited’s EPS decrease for this current 12-month fiscal period is -297.90% and is forecasted to reach 2.67 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 3.85% through the next 5 years, which can be compared against the -32.00% growth it accomplished over the previous five years trading on the market.

Teva Pharmaceutical Industries Limited (NYSE: TEVA) Trading Performance Indicators

Let’s observe the current performance indicators for Teva Pharmaceutical Industries Limited (TEVA). It’s Quick Ratio in the last reported quarter now stands at 0.70. The Stock has managed to achieve an average true range (ATR) of 0.27. Alongside those numbers, its PE Ratio stands at $12.48, and its Beta score is 1.31. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.57. Similarly, its price to free cash flow for trailing twelve months is now 104.78.

In the same vein, TEVA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.66, a figure that is expected to reach 0.73 in the next quarter, and analysts are predicting that it will be 2.67 at the market close of one year from today.

Technical Analysis of Teva Pharmaceutical Industries Limited (TEVA)

Now, what If we examine the latest scores posted by [Teva Pharmaceutical Industries Limited, TEVA]. During the last 5-days, its volume was lower the volume of 9.08 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 47.07% While, its Average True Range was 0.28.

>> 7 Top Picks for the Post-Pandemic Economy << 

Raw Stochastic average of Teva Pharmaceutical Industries Limited (TEVA) in the period of the previous 100 days is set at 10.86%, which indicates a major fall in contrast to 31.71% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 27.33% that was lower than 36.48% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free



Download Free eBook For


100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

Sign up for Our Newsletter Now! Discover which stocks to trade!
100% Free. Stop Anytime. No Spam